Biolegend, 311409, APC anti-human HLA-A,B,C Antibody, 25tests

MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8 + T cells. They play an important role in cell-mediated immune responses and tumor surveillance.
25tests
Verified Reactivity: Human, Cynomolgus, Rhesus
Reported Reactivity: African Green, Baboon, Cat, Cow, Chimpanzee
Antibody Type: Monoclonal
Host Species: Mouse
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser: Red Laser (633 nm)
Application Notes: Clone W6/32 recognizes residues in the N terminus of the human ß2-microglobulin molecule21.Additional reported applications (for the relevant formats) include: immunoprecipitaton2, Western blotting (non-reducing)3, immunohistochemical staining of acetone-fixed frozen tissue sections4,5, blocking6,7, inhibition of NK cell-mediated lysis10, and activation8,9. Clone W6/32 has been reported not to be suitable for immunohistochemistry on paraffin sections17. The LEAF™ purified antibody (Endotoxin < 0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays. For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 311428) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).
Application References(PubMed link indicates BioLegend citation): Darrow TL, et al. 1989. J. Immunol. 142:3329. Stern P, et al. 1987. J. Immunol. 138:1088. Tran TM, et al. 2001. Immunogenetics 53:440. Barbatis C, et al. 1981. Gut 22:985. Ayyoub M, et al. 2004. Cancer Immunity 4:7. DeFelice M, et al. 1990. Cell. Immunol. 126:420. Fayen J, et al. 1998. Int. Immunol. 10:1347. Turco MC, et al. 1988. J. Immunol. 141:2275. Geppert TD, et al. 1989. J. Immunol. 142:3763. Wooden SL, et al. 2005. J. Immunol. 175:1383. Nagano M, et al. 2007. Blood 110:151. McLoughlin RM,et al.2008. J. Immunol. 181:1323. PubMed Takahara M, et al.2008. J. Leukoc. Biol. 83:742. PubMed Lunemann A, et al.2008. J. Immunol. 181:6170. PubMed Laing BJ, et al. 2010. J. Thorac Cardiovasc Surg. 139:1402. PubMed Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC) Vambutas A, et al. 2000. Clin. Diagn. Lab. Immun. 7:79. Coppieters KT, et al. 2012. J. Exp. Med. 209:51. (epitope) Crivello P, et al. 2013. Hum Immunol. 22:100. PubMed Jung Y, et al. 2015. Mol Cancer Res. 13:197. PubMed Shields MJ. Ribaudo RK. 1998. Tissue Antigens. 51(5):567-70. (epitope)
Product Citations: Ho J, et al. 2016. PLoS Biol. 14:e2000117. PubMed Preece R, et al. 2020. Gene Ther. 451:27. PubMed Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed Hoke ATK, et al. 2021. Cancer Res Commun. 1:127. PubMed Kemble S, et al. 2022. Blood Adv. 6:2932. PubMed Gerace D, et al. 2023. Cell Rep Med. 4:100879. PubMed Tunali G, et al. 2023. J Clin Invest. :. PubMed Yoon HJ, et al. 2022. Exp Mol Med. Online ahead of print. PubMed Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed Zuo J, et al. 2011. J Virol. 85:1604. PubMed Foucras G, et al. 2011. J Immunol. 187:6564. PubMed Yamaguchi S, et al. 2021. Eur J Immunol. 51:2306. PubMed Charles A, et al. 2021. Oncoimmunology. 10:1916243. PubMed Kaseke C, et al. 2021. Cell Reports. 36(2):109378. PubMed Rosskopf S, et al. 2016. Sci Rep. 6:31580. PubMed Hashimoto M, et al. 2015. J Immunol. 95: 4341 - 4350. PubMed Choi J, et al. 2021. Cell Rep Methods. 1:100084. PubMed Madrid A, et al. 2012. J Virol. 86: 8693. PubMed Bachireddy P, et al. 2020. Sci Transl Med. :12. PubMed Mitchell K, et al. 2018. J Exp Med. 215:1709. PubMed Heusinger E, et al. 2018. J Virol. 92:18. PubMed Kula T, et al. 2019. Cell. 178:1016. PubMed Zhuang X, et al. 2020. Front Immunol. 2.415972222. PubMed Bondarenko M, et al. 2021. Cancers (Basel). 13: . PubMed Ren J, et al. 2022. J Clin Invest. . PubMed Massafra V, et al. 2021. J Immunol. 207:493. PubMed Nathan A, et al. 2021. Cell. 184(17):4401-4413.e10. PubMed Amabile A et al. 2016. Cell. 167(1):219-232 . PubMed Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed Lian W, et al. 2022. J Immunol Res. 2022:3129765. PubMed Mandrup OA, et al. 2021. Commun Biol. 310:4. PubMed Shan X et al. 2017. eLife. 6 pii: e25306. PubMed Bradley S, et al. 2015. Cancer Immunol Res. 3:602. PubMed Hashimoto M, et al. 2016. J Immunol. 1832 - 1841. PubMed Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed Io S, et al. 2021. Cell Stem Cell. 28(6):1023-1039.e13. PubMed Croft N, et al. 2009. PLoS One. 5:e1000490. PubMed Amo L, et al. 2022. Front Immunol. 13:835527. PubMed Okita R, et al. 2021. Thorac Cancer. 12:775. PubMed Usmani SM et al. 2019. Cell host & microbe. 25(1):73-86 . PubMed Slaine PD, et al. 2021. J Virol. 95:e00453. PubMed Bear AS, et al. 2021. Nat Commun. 12:4365. PubMed Lee JH, et al. 2020. Nat Commun. 11:1897. PubMed Yao C, et al. 2018. Autophagy. 1.854861111. PubMed Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed Sim MJW, et al. 2020. Proc Natl Acad Sci U S A. 117:12826. PubMed Dheilly E, et al. 2020. Cancer Cell. 37(5):674-689. PubMed Rainho J, et al. 2015. J Virol. 89: 10625 - 10636. PubMed Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed Alvino VV, et al. 2018. J Am Heart Assoc. 7:e006727. PubMed Lee PC, et al. 2022. J Clin Invest. 132:. PubMed Kimmel E, et al. 2011. Antiviral Res. 90:80. PubMed Joas S, et al. 2018. Nat Commun. 9:902. PubMed Joas S, et al. 2020. Cell Rep. 30:2261. PubMed Saif J, et al. 2010. Arterioscler Thromb Vasc Biol. 30:1897. PubMed
RRID: AB_314878 (BioLegend Cat. No. 311409) AB_314879 (BioLegend Cat. No. 311410)
Structure: Ig superfamily
Distribution: All nucleated cells
Function: Antigen presentation
Ligand/Receptor: CD3/TCR, CD8
Biology Area: Immunology, Innate Immunity
Molecular Family: MHC Antigens
Antigen References: 1. Barclay AN, et al. Eds. 1993. The Leukocyte Antigen FactsBook. Academic Press Inc. San Diego.
Gene ID: 3105
UniProt: View information about HLA-A on UniProt.org
Clone: W6/32
Regulatory Status: RUO
Other Names: Major Histocompatibility Class I, MHC class I
Isotype: Mouse IgG2a, κ